The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes indeed another good interview thanks for sharing...did anyone spot something in the print media? This time AB used the word imminent when it came to the farmout so anytime now and although its a pre announced event we knew it was coming its still a significant milestone showcasing the development of the company over the years. The farm out process will take time as companies will not rush this, although highly economic and as low risk as any oil development can be its still a big undertaking so I am prepared for 6 months waiting during which anything can happen. A buy out would of course speed this up massively and I would be happy to support it for as long as there is a good shareholder value and I am sure that management, accounting for 10% of the shares and a few more options, look at it the same way. So all doors are open...let the showdown begin! Good luck all holders.
I've now listened to the 9min 50secs interview, an excellent overview of what's happened and what's going to happen in the coming months. Cannot imagine any current shareholder going anywhere near the sell button. As you point out in your post, Dick any buyer is unlikely to stump up either of the figures highlighted by AB (£39/ £60 ) your £17 is not an unreasonable target (life changing for me). Would AB and his colleagues be content at that level, time will tell, how exciting. Stay well Dick.
LSE clearly doesn't like VM.
Type in Vox Markets (all lower case and no spaces)
Excellent find, alsoppc. Compelling stuff. The key to finding the podcast is to cut and paste the link provided into your browser. "This site can't be reached" will then appear on your screen. Delete the rubbish that appears in front of the ".co.uk/articles/amryt-pharma-record-fy-2020-results-jog-concept-select-update-russ-mould-on-the-bond-market-shock-fed3c09/" part of the web address and type in "**********" (obviously ignore the inverted commas I use that are intended to make things easier to follow).
Imv the best presentation yet from our esteemed leader (J Andrew B). He's a very impressive orator - a natural in front of the camera/microphone/whatever. He instills confidence in the listener that only needs to be followed up with the £39ps he refers to :-)
Maybe that sort of SP will be supported by the fundamentals a bit further down the line but, based on JOG's latest NPV (and taking into account the fact no buyer is ever going to pay a seller the full value of the whole project upfront to walk away with) a split of roughly 1/3rd to the seller and 2/3rds to the buyer (which is the party making all the future effort, putting up all the funds to get to first oil and of course taking all the future risks) might not be too far off the mark. In general, where M&As are concerned, it's all about the perceptions of the parties that are interested in the opportunity offered. If a potential opportunity is perceived as attractive it can lead to a "who wants it the most" type of situation. Competition inevitably drive prices up, so the more interest shown by the Industry in what JOG has to offer, the better. Maybe a 50/50 split (of NPV) would be closer to what's achievable than my 33/67; who knows? Anyway, I'll stick with the numbers I put forward last night (a SP of about £17 for all of us losers). Shame I'm not holding more but, looking on the bright side, one can only fly one helicopter at a time and more than one Princess 65 would be excessive :-)
I'm not making forecasts - I'm speculating. But what I'm putting forward doesn't seem that daft to me. It all really depends on how the O&G companies doing business (or wanting to do business) in the CNS view what's on offer. The declared intention is a farm out. But I'd much prefer (and I think it makes a lot more sense for shareholders) an outright acquisition of JOG, the prize being at least 170MMboe of 33°API oil in a highly attractive location, with development planning befitting of 21st century already carries out and paid for.
imo/dyor
I leave you with the following:
"The reality of life is that your perceptions — right or wrong — influence everything else you do. When you get a proper perspective of your perceptions, you may be surprised how many other things fall into place"
Roger Birkman
https://www.**********.co.uk/articles/amryt-pharma-record-fy-2020-results-jog-concept-select-update-russ-mould-on-the-bond-market-shock-fed3c09/
Problem pasting the link for some reason, it's a 10 min interview on Vox Markets incase it doesn't work this time either
https://www.**********.co.uk/articles/amryt-pharma-record-fy-2020-results-jog-concept-select-update-russ-mould-on-the-bond-market-shock-fed3c09/
More of the same really, this is the year, hope he's right